Cross‐presentation of a CMV pp65 epitope by human dendritic cells using bee venom PLA2 as a membrane‐binding vector

No abstract is available for this paper.

• Publication year

  2005

• Venue

  FEBS Letters

• Publication date

  2005-03-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.febslet.2005.02.019PMID 15757657
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Secretory phospholipase A2 induces dendritic cell maturation

  2004cited by this paper
• Alteration of the tertiary structure of the major bee venom allergen Api m 1 by multiple mutations is concomitant with low IgE reactivity

  2004cited by this paper
• Clinical applications of dendritic cell vaccination in the treatment of cancer

  2004cited by this paper
• Identification of the Ricin Lipase Site and Implication in Cytotoxicity*

  2003cited by this paper
• Naive CD8+ T cell recruitment and proliferation are dependent on stage of dendritic cell maturation

  2003cited by this paper
• A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.

  2003cited by this paper
• ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

  2003cited by this paper
• Phagosomes are competent organelles for antigen cross-presentation

  2003cited by this paper
• Dendritic cell-based cancer immunotherapy.

  2003cited by this paper
• ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum

  2002cited by this paper
• CD8+ T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients

  2002cited by this paper
• 1st Class Ticket to Class I: Protein Toxins as Pathfinders for Antigen Presentation

  2002influential reference
• Exogenous Peptides Delivered by Ricin Require Processing by Signal Peptidase for Transporter Associated with Antigen Processing-Independent MHC Class I-Restricted Presentation1

  2002influential reference
• Identification of a Clinical-Grade Maturation Factor for Dendritic Cells

  2002influential reference
• Molecular Mechanism and Structural Aspects of Transporter Associated with Antigen Processing Inhibition by the Cytomegalovirus Protein US6*

  2001influential reference
• Cross-presentation in viral immunity and self-tolerance

  2001cited by this paper
• Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids

  2000cited by this paper
• Immunotherapy with Dendritic Cells Directed against Tumor Antigens Shared with Normal Host Cells Results in Severe Autoimmune Disease

  2000cited by this paper
• Incoming Human Cytomegalovirus pp65 (UL83) Contained in Apoptotic Infected Fibroblasts Is Cross-Presented to CD8+ T Cells by Dendritic Cells

  2000cited by this paper
• Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses.

  2000cited by this paper
• Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells.

  2000cited by this paper
• Simplified Method to Generate Large Quantities of Dendritic Cells Suitable for Clinical Applications

  2000cited by this paper
• Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus.

  1999influential reference
• Intracellular Delivery of a Cytolytic T-Lymphocyte Epitope Peptide by Pertussis Toxin to Major Histocompatibility Complex Class I without Involvement of the Cytosolic Class I Antigen Processing Pathway

  1999cited by this paper
• Direct Pathway from Early/Recycling Endosomes to the Golgi Apparatus Revealed through the Study of Shiga Toxin B-fragment Transport

  1998influential reference
• Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations.

  1997cited by this paper
• Lactacystin and clasto-Lactacystin β-Lactone Modify Multiple Proteasome β-Subunits and Inhibit Intracellular Protein Degradation and Major Histocompatibility Complex Class I Antigen Presentation*

  1997cited by this paper
• The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL

  1996cited by this paper
• Active site of bee venom phospholipase A2: the role of histidine-34, aspartate-64 and tyrosine-87.

  1996cited by this paper
• Membrane transport in the endocytic pathway.

  1995influential reference
• Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump

  1995cited by this paper
• Fine chemical modifications at N- and C-termini enhance peptide presentation to T cells by increasing the lifespan of both free and MHC-complexed peptides.

  1995cited by this paper
• Adenovirus-Mediated Transfer of the CFTR Gene to Lung of Nonhuman Primates: Toxicity Study

  1993cited by this paper
• High-level expression in Escherichia coli and rapid purification of enzymatically active honey bee venom phospholipase A2.

  1992cited by this paper
• Interfacial catalysis by phospholipase A2: dissociation constants for calcium, substrate, products, and competitive inhibitors.

  1991cited by this paper

• Antiviral attributes of bee venom as a possible therapeutic approach against SARS-CoV-2 infection

  2023cites this paper
• Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections

  2020cites this paper
• Bee venom phospholipase A2 as a membrane-binding vector for cell surface display or internalization of soluble proteins.

  2016influential citation
• Bee Venom Phospholipase A2: Yesterday’s Enemy Becomes Today’s Friend

  2016cites this paper
• Engineering of bacterial toxins for research and medicine

  2015cites this paper
• Bee Venom Phospholipase A2, a Good “Chauffeur” for Delivering Tumor Antigen to the MHC I and MHC II Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1

  2013cites this paper
• Vaccine therapy with dendritic cells transfected with Il13ra2 mRNA for glioma in mice.

  2010cites this paper
• Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model.

  2007cites this paper
• CHAPTER 60 – Engineering of bacterial toxins for research and medicine

  2006cites this paper
• Antitumor action and immune activation through cooperation of bee venom secretory phospholipase A2 and phosphatidylinositol-(3,4)-bisphosphate

  2006cites this paper